Related Experiment Videos
The immune response to HTLV-I
1Department of Immunology, Imperial College School of Medicine, London, W2 1PG, UK. c.bangham@ic.ac.uk
Current Opinion in Immunology
|July 19, 2000
Summary
A strong cytotoxic T lymphocyte response to Human T-lymphotropic virus type I (HTLV-I) protects against central nervous system inflammation. However, high HTLV-I proviral loads can cause these T cells to contribute to disease pathogenesis.
Area of Science:
- Immunology
- Virology
- Neuroscience
Background:
- Human T-lymphotropic virus type I (HTLV-I) causes inflammatory diseases of the central nervous system, such as HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
- The role of cytotoxic T lymphocyte (CTL) responses in HTLV-I pathogenesis is complex and not fully understood.
Purpose of the Study:
- To investigate the dual role of HTLV-I-specific CTL responses in the context of viral load and central nervous system inflammation.
Main Methods:
- Analysis of CTL responses in relation to HTLV-I proviral load.
- Assessment of the impact of CTLs on disease progression in HAM/TSP.
Main Results:
- A strong HTLV-I-specific CTL response is associated with reduced proviral load, conferring protection against HAM/TSP.
- Elevated proviral load thresholds can shift the function of HTLV-I-specific CTLs, potentially contributing to neuroinflammation.
Conclusions:
- HTLV-I-specific CTLs play a protective role by controlling viral replication at lower loads.
- At higher proviral loads, CTLs may paradoxically exacerbate inflammation, highlighting a critical threshold effect in HTLV-I pathogenesis.